Pharmacogenomics of Nicotine Dependence and Impact on Smoking Cessation

Publisher： Bentham Science Publishers

E-ISSN： 1875-6204|5|3|178-189

ISSN： 1570-1603

Source： Current Pharmacogenomics, Vol.5, Iss.3, 2007-09, pp. : 178-189

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent developments for smoking cessation and treatment of nicotine dependence

By Balbani Aracy PS   Montovani Jair C  

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 3, 2007-03 ,pp. : 287-297

Informa Healthcare

Access to resources Recommend Favorite

Promise of pharmacogenomics in smoking cessation

By Uhl George R  

Pharmacogenomics, Vol. 10, Iss. 7, 2009-07 ,pp. : 1123-1125

Future Medicine

Access to resources Recommend Favorite

A nicotine vaccine for smoking cessation

By  

Inpharma, Vol. 1, Iss. 1359, 2002-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Role of the Glutamatergic System in Nicotine Dependence: Implications for the Discovery and Development of New Pharmacological Smoking Cessation Therapies

By Liechti Matthias E.  

CNS Drugs, Vol. 22, Iss. 9, 2008-01 ,pp. : 705-724

Adis International

Access to resources Recommend Favorite

Genetic variation in three candidate genes and nicotine dependence, withdrawal and smoking cessation in hospitalized patients

By De Ruyck Kim   Nackaerts Kristiaan   Beels Laurence   Werbrouck Joke   De Volder Annick   Meysman Marc   Salhi Bihiyga   Van Meerbeeck Jan   Thierens Hubert  

Pharmacogenomics, Vol. 11, Iss. 8, 2010-08 ,pp. : 1053-1063

Future Medicine

Access to resources Recommend Favorite